Ionova Life Science - Crunchbase Company Profile & Funding

Q: Who invested in Ionova Life Science?

Ionova Life Science has 4 investors including Lilly Asia Ventures And Shenzhen Capital Group.

Q: How much funding has Ionova Life Science raised to date?

Ionova Life Science has raised obfuscated.

Overview

Ionova Life Science

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Ionova Life Science

CB Rank

70686

Ionova Life Science IS a biotech company.

Founded

obfuscation

Private

Venture - Series Unknown

Shenzhen, Guangdong, China

51-100

www.ionovabio.com/

Biopharma

Biotechnology

Health Care

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Yongkui Sun: Founder, Chairman of the Board and CEO
Feng Roger Luo: Chief Development Officer
Past Role: ACEA BIO, Vice President, Head of Global Development

Details

Legal Name

Shenzhen Yuanli Life Science Co., Ltd.

Also Known As

原力生命

Operating Status

Active

Company Type

For Profit

Founders

Yongkui Sun

About the Company

Ionova Life Science is an anti-tumor drug developer dedicated to the development of innovative types of tumor-targeted drugs and tumor immunomodulatory drugs, including oncology, immuno-oncology, and cardiac metabolic diseases. Force contact

Phone Number

+86 0757-82581376

Contact Email

info@ionovabio.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

INV-9956

A CYP11A1 inhibitor developed for cancer therapy, currently approved for clinical trials by regulatory authorities.

INV-1120

An EP4 antagonist designed for cancer immunotherapy, undergoing phase 1b clinical trials in combination with Keytruda® for advanced solid tumors.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Ionova Life Science	4	obfuscated obfuscation	Qingsong Capital, Shenzhen Capital Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ionova Life Science	4	obfuscated obfuscation	Qingsong Capital, Shenzhen Capital Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ionova Life Science	4	obfuscated obfuscation	Qingsong Capital, Shenzhen Capital Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ionova Life Science	4	obfuscated obfuscation	Qingsong Capital, Shenzhen Capital Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ionova Life Science	4	obfuscated obfuscation	Qingsong Capital, Shenzhen Capital Group	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Ionova Life Science	4	obfuscated obfuscation	Qingsong Capital, Shenzhen Capital Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ionova Life Science	4	obfuscated obfuscation	Qingsong Capital, Shenzhen Capital Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ionova Life Science	4	obfuscated obfuscation	Qingsong Capital, Shenzhen Capital Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ionova Life Science	4	obfuscated obfuscation	Qingsong Capital, Shenzhen Capital Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ionova Life Science	4	obfuscated obfuscation	Qingsong Capital, Shenzhen Capital Group	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Lilly Asia Ventures	—	Venture Round - Ionova Life Science	—
Lilly Asia Ventures	—	Venture Round - Ionova Life Science	—
Lilly Asia Ventures	—	Venture Round - Ionova Life Science	—
Lilly Asia Ventures	—	Venture Round - Ionova Life Science	—
Lilly Asia Ventures	—	Venture Round - Ionova Life Science	—